Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Gibco is a premier brand under Thermo Fisher Scientific, specializing in cell culture media, reagents, and sera essential for biological research and biopharmaceutical manufacturing. Founded in 1962 as the Grand Island Biological Company, it has become a global leader in providing standardized and customized solutions for cell growth, including specialized media for stem cells, primary cells, and production-scale bioprocessing. The brand is particularly noted for its Cell Therapy Systems (CTS) product line, which supports the transition from basic research to clinical applications. Gibco's portfolio also encompasses protein expression systems, cell line development services, and chemical-defined media designed to enhance yield and consistency in drug production. As a cornerstone of the life sciences industry, Gibco products are utilized in the development of vaccines, monoclonal antibodies, and advanced cell and gene therapies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Gibco.